HUTCHMED (China) (HCM) Total Liabilities (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Total Liabilities came in at $64.5 million in Q4 2025, little changed year-on-year from $64.6 million in Q4 2024, and down 87.92% on a QoQ basis from $534.0 million in Q2 2025.
HUTCHMED (China) (HCM) Total Liabilities (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Total Liabilities data on file, last reported at $64.5 million in Q4 2025.
- On a quarterly basis, Total Liabilities changed 0.14% year-over-year to $64.5 million in Q4 2025; TTM through Dec 2025 was $64.5 million, a 0.14% change from a year earlier, with the FY2025 full-year figure at $64.5 million, changed 0.22% from the prior year.
- Total Liabilities for Q4 2025 stood at $64.5 million, down from $534.0 million in the prior quarter.
- Over the last five years, Total Liabilities for HCM reached as high as $534.0 million in Q2 2025 and fell as low as $68647.0 in Q4 2023.
- Historically, Total Liabilities has averaged $235.7 million across 5 years, with a median of $228.7 million in 2021.
- Across the five-year window, Total Liabilities plunged 99.86% in 2023 and soared 94029.23% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $42.8 million in 2021, then gained by 17.34% to $50.2 million in 2022, then plunged by 99.86% to $68647.0 in 2023, then soared by 94029.23% to $64.6 million in 2024, then slipped by 0.14% to $64.5 million in 2025.
- Per Business Quant data, the three most recent Total Liabilities figures were $64.5 million in Q4 2025, $534.0 million in Q2 2025, and $64.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 64.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.52 Mn |
| Jun 30, 2025 | 534.02 Mn |
| Dec 31, 2024 | 64.62 Mn |
| Jun 30, 2024 | 508.85 Mn |
| Dec 31, 2023 | 68,646.96 |
| Jun 30, 2023 | 497.48 Mn |
| Dec 31, 2022 | 50.19 Mn |
| Jun 30, 2022 | 342.48 Mn |
| Dec 31, 2021 | 42.77 Mn |
| Jun 30, 2021 | 259.19 Mn |
| Mar 31, 2021 | 228.72 Mn |
| Dec 31, 2020 | 624.10 Mn |
| Jun 30, 2020 | 158.51 Mn |
| Dec 31, 2019 | 412.12 Mn |
| Sep 30, 2019 | 116.31 Mn |
| Jun 30, 2019 | 122.18 Mn |
| Mar 31, 2019 | 138.94 Mn |
| Dec 31, 2018 | 119.86 Mn |
| Jun 30, 2018 | 120.10 Mn |
| Dec 31, 2017 | 112.97 Mn |